“supplement stack”的搜索结果，显示 471-480 项，共有 8118 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to understand pain outcomes in patients with cancer who have Chemotherapy-Induced Peripheral Neuropathy (CIPN). IL ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer.

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The objectives of this study are to analyze impact of radiation on fertility, to correlate the clinical outcome of fertility after chemotherapy and or ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of this study is to determine the prevalence of genetic mutations in cancer patients from various ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This study aims to identify candidate High Grade Serous Cancer (HGSC) early detection and chemotherapy treatment response biomarkers. For the ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate olaparib and temozolomide in treating patients with uterine leiomyosarcoma (LMS) that has spread to other places of ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer.

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the reduction in the peritoneal carcinomatosis index (PCI) after completion of the study treatment.

10. 泼尼松和其他皮质类固醇

    皮质类固醇药物用于治疗类风湿关节炎、炎性肠病（IBD）、哮喘、过敏及其他诸多病症。这类药物也可用于防止器官移植受体出现器官排斥反应，即通过帮助抑制免疫系统来实现。